HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit an electronic Letter to the Editor about this paper Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (2) Citing Articles via Google Scholar Google Scholar Articles by Haverstick, D. M. Articles by Bruns, D. E. Search for Related Content PubMed PubMed Citation Articles by Haverstick, D. M. Articles by Bruns, D. E. Related Collections Molecular Diagnostics and Genetics Clinical Immunology Proteomics and Protein Markers Automation and Analytical Techniques

Genotyping of Hepatitis C Virus by Melting Curve Analysis: Analytical Characteristics and Performance

¹ Department of Pathology, University of Virginia, Charlottesville, VA

^aaddress correspondence to this author at: Department of Pathology, University of Virginia Medical School, PO Box 800214, Charlottesville, VA 22908-0214; fax 434-924-8060, e-mail dmh2t@virginia.edu

The first 20% of the full text of this article appears below.

Knowledge of the hepatitis C virus (HCV) genotype is important in guiding antiviral therapy (1). Viral pharmacogenomic studies have demonstrated that patients infected with genotype-1 HCV respond poorly to interferon-ribavirin therapy and may require a longer course of therapy (1)(2)(3). In the United States, where the most common HCV types are 1a/b, 2a/c, 2b, and 3a, it is particularly important to distinguish patients infected with type 1a/b from those infected with types 2 and 3. To meet the need for this information, we have developed a rapid-cycle, real-time PCR assay with melting-curve analysis for genotyping of HCV (4). This method uses reverse transcription-PCR performed in a block cycler followed by a seminested PCR with product identification using fluorescence resonance energy transfer (FRET) probes and DNA melting curves in a single tube. The FRET probes were designed to identify HCV types 1, 2a/c, 2b, 3a, and 3b/4. Other less common genotypes will likely either not be amplified (types 6b, 7b, and 11a) or will produce a product with a non-type 1 melting temperature (T_m) (4).

Real-time PCR has gained widespread use in clinical analyses since its introduction in 1991 (5), but little has been published on the performance characteristics of such assays over periods longer than a few days or weeks. The objective of the present study was to determine the analytical characteristics of the above HCV genotyping assay and its performance in routine use. The study period covered 23 months with 92 runs performed by six operators on four different LightCycler® instruments, using the exact assay described above . . . [Full Text of this Article]

The following articles in journals at HighWire Press have cited this article:

				N. Uemura, K. Makimura, M. Onozaki, Y. Otsuka, Y. Shibuya, H. Yazaki, Y. Kikuchi, S. Abe, and S. Kudoh Development of a loop-mediated isothermal amplification method for diagnosing Pneumocystis pneumonia J. Med. Microbiol., January 1, 2008; 57(1): 50 - 57. [Abstract] [Full Text] [PDF]